Catalyst Financial Statements From 2010 to 2024
| CBIODelisted Stock | USD 7.67 0.83 9.76% |
Check Catalyst Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Catalyst financial statements analysis is a perfect complement when working with Catalyst Biosciences Valuation or Volatility modules.
Catalyst |
Catalyst Biosciences Company Shares Outstanding Analysis
Catalyst Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Catalyst Biosciences Shares Outstanding | 37.97 M |
Most of Catalyst Biosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalyst Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Catalyst Biosciences has 37.97 M of shares currently outstending. This is 78.97% lower than that of the Biotechnology sector and 64.46% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 93.36% higher than that of the company.
Catalyst Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Catalyst Biosciences's current stock value. Our valuation model uses many indicators to compare Catalyst Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Catalyst Biosciences competition to find correlations between indicators driving Catalyst Biosciences's intrinsic value. More Info.Catalyst Biosciences is rated fourth in return on equity category among related companies. It is rated second in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Catalyst Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Catalyst Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Catalyst Biosciences' earnings, one of the primary drivers of an investment's value.About Catalyst Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Catalyst Biosciences income statement, its balance sheet, and the statement of cash flows. Catalyst Biosciences investors use historical funamental indicators, such as Catalyst Biosciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although Catalyst Biosciences investors may use each financial statement separately, they are all related. The changes in Catalyst Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Catalyst Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Catalyst Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Catalyst Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California. Catalyst Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Catalyst Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Catalyst Biosciences' short interest history, or implied volatility extrapolated from Catalyst Biosciences options trading.
Pair Trading with Catalyst Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Catalyst Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Biosciences to buy it.
The correlation of Catalyst Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |